This inventor holds 2 USPTO granted patents. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Austin Keith Doyle: Innovator in Antibody Engineering
Introduction
Austin Keith Doyle is a prominent inventor based in Stevenage, GB. He has made significant contributions to the field of antibody engineering, holding a total of 2 patents. His work focuses on improving the bioavailability of antibodies for subcutaneous administration in humans.
Latest Patents
Doyle's latest patents revolve around antibody variants. The present invention relates to methods of selecting, screening, engineering, making, and modifying antibodies that have improved bioavailability upon subcutaneous administration to a human. Antibodies and variant antibodies with enhanced bioavailability are also described in his patents.
Career Highlights
Austin Keith Doyle is associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in antibody engineering. His innovative approaches have the potential to significantly impact therapeutic applications.
Collaborations
Some of his notable coworkers include Valeriu Damian and Laura Maria Halo, who contribute to the collaborative efforts in their research and development projects.
Conclusion
Austin Keith Doyle's work in antibody engineering exemplifies the innovative spirit of modern science. His contributions are paving the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile